19117345Kantarjian HM, Larson RA, Guilhot F, O'Brien SG, Mone M, Rudoltz M, Krahnke T, Cortes J, Druker BJ, International Randomized Study of Interferon and STI571 (IRIS) InvestigatorsCancerLeukemia, Myeloid, Chronic-Phase; Piperazines; PyrimidinesBenzamides; Clinical Trials as Topic; Disease-Free Survival; Drug Administration Schedule; Imatinib Mesylate; Survival Analysis; Treatment OutcomeEfficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase. Cancer. 2009 Feb 01; 115(3):551-60.Cancer2009-02-01T00:00:002009Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD001549Chemicals & Drugs942260.914079BenzamidesD010879Chemicals & Drugs1102720.858236PiperazinesAuthorship 370062Medicine-Hematology and OncologyD016896Concepts & Ideas101179490.402421Treatment Outcome0.08744980.08744981authors10.2510has subject areaD011743Chemicals & Drugs1373700.795286PyrimidinesD016019Concepts & Ideas43415360.742939Survival AnalysisD015466Disorders5240.982815Leukemia, Myeloid, Chronic-PhaseD002986Procedures32811680.665262Clinical Trials as TopicD000068877451260.961428Imatinib MesylateD004334Concepts & Ideas2609160.852436Drug Administration ScheduleD018572Concepts & Ideas25812030.792724Disease-Free SurvivalUniversity of ChicagoRichard A.LarsonRichard A. Larson41.78927490000000-87.601250000000001169Larson, Richard A.Professortrue1ProfessorProfessor